Cholesterol after stroke: doing better
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is for people who recently had a stroke or TIA and have high cholesterol. It aims to see how well different cholesterol-lowering treatments work to prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke or TIA in the last 30 days.
- A LDL ('bad') cholesterol test was done around that time.
- Your doctor has prescribed a cholesterol-lowering treatment (e.g., statin, diet, or other medicine).
- You can come back for a follow-up visit in about 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing the best target for 'bad' cholesterol (LDL) after a type of stroke caused by a small blocked vessel. You would be in one of two groups to see which LDL level helps prevent another stroke the most.
This trial compares two treatments for people who recently had a stroke or TIA and have high cholesterol with artery plaque. Some participants will get a combination of two cholesterol-lowering medicines (statin and ezetimibe), while others will get only a statin.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This trial tests if adding a PCSK9 inhibitor (a newer cholesterol-lowering medicine) to standard care helps people who had a stroke from a large artery blockage and had a clot-removal procedure. It may lower bad cholesterol further and reduce the risk of another stroke.
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Hear when a new Stroke (CVA) or Transient Ischemic Attack trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.